Annual Total Assets
$33.08 B
+$3.87 B+13.23%
31 December 2023
Summary:
Regeneron Pharmaceuticals annual total assets is currently $33.08 billion, with the most recent change of +$3.87 billion (+13.23%) on 31 December 2023. During the last 3 years, it has risen by +$15.92 billion (+92.74%). REGN annual total assets is now at all-time high.REGN Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$37.44 B
+$1.36 B+3.76%
30 September 2024
Summary:
Regeneron Pharmaceuticals quarterly total assets is currently $37.44 billion, with the most recent change of +$1.36 billion (+3.76%) on 30 September 2024. Over the past year, it has increased by +$5.28 billion (+16.41%). REGN quarterly total assets is now at all-time high.REGN Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REGN Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.2% | +16.4% |
| 3 y3 years | +92.7% | +58.2% |
| 5 y5 years | +181.9% | +168.6% |
REGN Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +92.7% | at high | +58.2% |
| 5 y | 5 years | at high | +181.9% | at high | +168.6% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Regeneron Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $37.44 B(+3.8%) |
| June 2024 | - | $36.09 B(+5.0%) |
| Mar 2024 | - | $34.37 B(+3.9%) |
| Dec 2023 | $33.08 B(+13.2%) | $33.08 B(+2.9%) |
| Sept 2023 | - | $32.16 B(+4.9%) |
| June 2023 | - | $30.66 B(+2.0%) |
| Mar 2023 | - | $30.06 B(+2.9%) |
| Dec 2022 | $29.21 B(+14.9%) | $29.21 B(+5.6%) |
| Sept 2022 | - | $27.68 B(+1.7%) |
| June 2022 | - | $27.21 B(+3.3%) |
| Mar 2022 | - | $26.35 B(+3.6%) |
| Dec 2021 | $25.43 B(+48.2%) | $25.43 B(+7.4%) |
| Sept 2021 | - | $23.67 B(+10.2%) |
| June 2021 | - | $21.49 B(+20.9%) |
| Mar 2021 | - | $17.77 B(+3.5%) |
| Dec 2020 | $17.16 B(+15.9%) | $17.16 B(+6.7%) |
| Sept 2020 | - | $16.08 B(+11.5%) |
| June 2020 | - | $14.43 B(-8.4%) |
| Mar 2020 | - | $15.76 B(+6.4%) |
| Dec 2019 | $14.81 B(+26.2%) | $14.81 B(+6.2%) |
| Sept 2019 | - | $13.94 B(+5.8%) |
| June 2019 | - | $13.17 B(+2.5%) |
| Mar 2019 | - | $12.85 B(+9.5%) |
| Dec 2018 | $11.73 B(+33.9%) | $11.73 B(+8.6%) |
| Sept 2018 | - | $10.81 B(+8.6%) |
| June 2018 | - | $9.95 B(+6.2%) |
| Mar 2018 | - | $9.37 B(+6.9%) |
| Dec 2017 | $8.76 B(+25.7%) | $8.76 B(+0.7%) |
| Sept 2017 | - | $8.70 B(+7.3%) |
| June 2017 | - | $8.11 B(+3.7%) |
| Mar 2017 | - | $7.82 B(+12.1%) |
| Dec 2016 | $6.97 B(+24.3%) | $6.97 B(+2.1%) |
| Sept 2016 | - | $6.83 B(+10.0%) |
| June 2016 | - | $6.20 B(+5.1%) |
| Mar 2016 | - | $5.90 B(+5.3%) |
| Dec 2015 | $5.61 B(+46.2%) | $5.61 B(+8.2%) |
| Sept 2015 | - | $5.18 B(+14.5%) |
| June 2015 | - | $4.53 B(+7.8%) |
| Mar 2015 | - | $4.20 B(+9.4%) |
| Dec 2014 | $3.84 B(+30.0%) | $3.84 B(+2.6%) |
| Sept 2014 | - | $3.74 B(+8.2%) |
| June 2014 | - | $3.46 B(+6.0%) |
| Mar 2014 | - | $3.26 B(+10.5%) |
| Dec 2013 | $2.95 B(+41.8%) | $2.95 B(+11.8%) |
| Sept 2013 | - | $2.64 B(+11.0%) |
| June 2013 | - | $2.38 B(+4.5%) |
| Mar 2013 | - | $2.28 B(+9.4%) |
| Dec 2012 | $2.08 B(+57.2%) | $2.08 B(+25.3%) |
| Sept 2012 | - | $1.66 B(+13.9%) |
| June 2012 | - | $1.46 B(+8.0%) |
| Mar 2012 | - | $1.35 B(+2.0%) |
| Dec 2011 | $1.32 B(+21.5%) | $1.32 B(+34.6%) |
| Sept 2011 | - | $983.03 M(-6.1%) |
| June 2011 | - | $1.05 B(-2.6%) |
| Mar 2011 | - | $1.07 B(-1.4%) |
| Dec 2010 | $1.09 B(+47.0%) | $1.09 B(+15.6%) |
| Sept 2010 | - | $942.43 M(+19.2%) |
| June 2010 | - | $790.64 M(+0.4%) |
| Mar 2010 | - | $787.16 M(+6.2%) |
| Dec 2009 | $741.20 M(+2.3%) | $741.20 M(-0.1%) |
| Sept 2009 | - | $742.19 M(-0.0%) |
| June 2009 | - | $742.35 M(+8.9%) |
| Mar 2009 | - | $681.42 M(-5.9%) |
| Dec 2008 | $724.22 M(-22.6%) | $724.22 M(-12.3%) |
| Sept 2008 | - | $825.89 M(-3.0%) |
| June 2008 | - | $851.23 M(-8.6%) |
| Mar 2008 | - | $930.88 M(-0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $936.26 M(+60.0%) | $936.26 M(+63.4%) |
| Sept 2007 | - | $573.10 M(-4.1%) |
| June 2007 | - | $597.86 M(-0.6%) |
| Mar 2007 | - | $601.43 M(+2.8%) |
| Dec 2006 | $585.09 M(+38.2%) | $585.09 M(+64.7%) |
| Sept 2006 | - | $355.19 M(-6.1%) |
| June 2006 | - | $378.33 M(-5.9%) |
| Mar 2006 | - | $402.09 M(-5.1%) |
| Dec 2005 | $423.50 M(-10.5%) | $423.50 M(+1.0%) |
| Sept 2005 | - | $419.27 M(-6.2%) |
| June 2005 | - | $446.95 M(-5.0%) |
| Mar 2005 | - | $470.29 M(-0.6%) |
| Dec 2004 | $473.11 M(-1.3%) | $473.11 M(+0.1%) |
| Sept 2004 | - | $472.69 M(-3.2%) |
| June 2004 | - | $488.17 M(-3.6%) |
| Mar 2004 | - | $506.18 M(+5.6%) |
| Dec 2003 | $479.56 M(+22.5%) | $479.56 M(-4.2%) |
| Sept 2003 | - | $500.50 M(+26.5%) |
| June 2003 | - | $395.55 M(-8.1%) |
| Mar 2003 | - | $430.44 M(+9.9%) |
| Dec 2002 | $391.57 M(-21.0%) | $391.57 M(-6.5%) |
| Sept 2002 | - | $418.59 M(-5.0%) |
| June 2002 | - | $440.45 M(-6.7%) |
| Mar 2002 | - | $471.87 M(-4.8%) |
| Dec 2001 | $495.40 M(+137.9%) | $495.40 M(+55.5%) |
| Sept 2001 | - | $318.61 M(-5.3%) |
| June 2001 | - | $336.30 M(-3.7%) |
| Mar 2001 | - | $349.19 M(+67.7%) |
| Dec 2000 | $208.27 M(+52.0%) | $208.27 M(-3.7%) |
| Sept 2000 | - | $216.32 M(+7.0%) |
| June 2000 | - | $202.12 M(+53.1%) |
| Mar 2000 | - | $132.03 M(-3.6%) |
| Dec 1999 | $137.00 M(-12.7%) | $137.00 M(+1.9%) |
| Sept 1999 | - | $134.40 M(-3.9%) |
| June 1999 | - | $139.80 M(-6.4%) |
| Mar 1999 | - | $149.30 M(-4.8%) |
| Dec 1998 | $156.90 M(-6.8%) | $156.90 M(-3.4%) |
| Sept 1998 | - | $162.40 M(-1.6%) |
| June 1998 | - | $165.10 M(+2.3%) |
| Mar 1998 | - | $161.40 M(-4.2%) |
| Dec 1997 | $168.40 M(+22.4%) | $168.40 M(+2.2%) |
| Sept 1997 | - | $164.70 M(-3.1%) |
| June 1997 | - | $170.00 M(+31.7%) |
| Mar 1997 | - | $129.10 M(-6.2%) |
| Dec 1996 | $137.60 M(+46.7%) | $137.60 M(+5.4%) |
| Sept 1996 | - | $130.60 M(-6.2%) |
| June 1996 | - | $139.30 M(+61.6%) |
| Mar 1996 | - | $86.20 M(-8.1%) |
| Dec 1995 | $93.80 M(-0.4%) | $93.80 M(+26.4%) |
| Sept 1995 | - | $74.20 M(-11.0%) |
| June 1995 | - | $83.40 M(-3.1%) |
| Mar 1995 | - | $86.10 M(-8.6%) |
| Dec 1994 | $94.20 M(-19.9%) | $94.20 M(-3.3%) |
| Sept 1994 | - | $97.40 M(-7.9%) |
| June 1994 | - | $105.70 M(-0.3%) |
| Mar 1994 | - | $106.00 M(-9.9%) |
| Dec 1993 | $117.60 M(+20.1%) | $117.60 M(-6.6%) |
| Sept 1993 | - | $125.90 M(+52.8%) |
| June 1993 | - | $82.40 M(-9.1%) |
| Mar 1993 | - | $90.60 M(-7.5%) |
| Dec 1992 | $97.90 M(-14.1%) | $97.90 M(-6.2%) |
| Sept 1992 | - | $104.40 M(-4.0%) |
| June 1992 | - | $108.70 M(-3.1%) |
| Mar 1992 | - | $112.20 M(-1.6%) |
| Dec 1991 | $114.00 M(+348.8%) | $114.00 M(0.0%) |
| Sept 1991 | - | $114.00 M(-1.0%) |
| June 1991 | - | $115.20 M(+353.5%) |
| Dec 1990 | $25.40 M | $25.40 M |
FAQ
- What is Regeneron Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual total assets year-on-year change?
- What is Regeneron Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly total assets year-on-year change?
What is Regeneron Pharmaceuticals annual total assets?
The current annual total assets of REGN is $33.08 B
What is the all time high annual total assets for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual total assets is $33.08 B
What is Regeneron Pharmaceuticals annual total assets year-on-year change?
Over the past year, REGN annual total assets has changed by +$3.87 B (+13.23%)
What is Regeneron Pharmaceuticals quarterly total assets?
The current quarterly total assets of REGN is $37.44 B
What is the all time high quarterly total assets for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly total assets is $37.44 B
What is Regeneron Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, REGN quarterly total assets has changed by +$5.28 B (+16.41%)